Description

📄 Product Description (Optimized + Informative)

Tofajak 5 mg contains Tofacitinib, a Janus kinase (JAK) inhibitor used to treat Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis. Manufactured by Cipla, a trusted name in pharmaceuticals, this medication offers an effective oral treatment alternative for patients who have not responded well to conventional DMARDs (Disease-Modifying Anti-Rheumatic Drugs).

Tofajak helps reduce joint pain, stiffness, inflammation, and damage, improving quality of life and mobility in chronic autoimmune conditions.

⚠️ Dosage & Usage Instructions

• 🔹 Typical Adult Dose: 5 mg twice daily (as prescribed by your physician).

• 🔹 Take with or without food.

• 🔹 Do not crush or split the tablet.

• 🔹 Always follow the prescribed dosage schedule.

• 🔹 Regular blood tests may be required to monitor liver function, cholesterol, and white blood cell count.

⚠️ Warnings:

• Not suitable for patients with serious infections or liver disease.

• Avoid use during pregnancy or breastfeeding unless advised by a doctor.

• Avoid live vaccines while on this medication.